TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 28 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $5,000 | -64.3% | 10,307 | -50.1% | 0.00% | – |
| Q3 2016 | $14,000 | -61.1% | 20,671 | +14.2% | 0.00% | – |
| Q2 2016 | $36,000 | +500.0% | 18,097 | +593.4% | 0.00% | – |
| Q1 2016 | $6,000 | -33.3% | 2,610 | +121.2% | 0.00% | – |
| Q4 2015 | $9,000 | -18.2% | 1,180 | -31.3% | 0.00% | – |
| Q1 2015 | $11,000 | -75.0% | 1,717 | -77.0% | 0.00% | -100.0% |
| Q4 2014 | $44,000 | -56.4% | 7,457 | -49.2% | 0.00% | -50.0% |
| Q3 2014 | $101,000 | – | 14,679 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 467,639 | $4,868,000 | 0.47% |
| SPHERA FUNDS MANAGEMENT LTD. | 100,000 | $1,041,000 | 0.24% |
| DAFNA Capital Management LLC | 25,000 | $260,000 | 0.22% |
| BLUESTEIN R H & CO LLC | 286,100 | $2,978,000 | 0.20% |
| WALL STREET ASSOCIATES | 200,000 | $2,082,000 | 0.17% |
| SABBY MANAGEMENT, LLC | 275,000 | $2,863,000 | 0.16% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 275,000 | $2,860,000 | 0.15% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 147,747 | $1,538,000 | 0.10% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 244,524 | $2,545,000 | 0.10% |
| Lombard Odier Asset Management (USA) Corp | 239,500 | $2,493,000 | 0.10% |